These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 29063635)

  • 1. Immunogenicity of a Glycoconjugate from Hydrazine-Detoxified Lipopolysaccharide of Vibrio cholerae O139.
    Fleischhackerová-Slimáková A; Korcová J; Bystrický S
    Scand J Immunol; 2017 Dec; 86(6):444-451. PubMed ID: 29063635
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and immunogenicity of conjugate based on hydrazine-treated lipopolysaccharide antigen of Vibrio cholerae O139.
    Fleischhackerová A; Farkaš P; Cížová A; Bystrický S
    Biosci Biotechnol Biochem; 2014; 78(11):1817-24. PubMed ID: 25070088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation, immunogenicity, and protective efficacy, in a murine model, of a conjugate vaccine composed of the polysaccharide moiety of the lipopolysaccharide of Vibrio cholerae O139 bound to tetanus toxoid.
    Boutonnier A; Villeneuve S; Nato F; Dassy B; Fournier JM
    Infect Immun; 2001 May; 69(5):3488-93. PubMed ID: 11292781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vibrio cholerae O139 capsular polysaccharide confers complement resistance in the absence or presence of antibody yet presents a productive target for cell lysis: implications for detection of bactericidal antibodies.
    Attridge SR; Holmgren J
    Microb Pathog; 2009 Dec; 47(6):314-20. PubMed ID: 19818394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain.
    Altman E; Chandan V; Harrison BA; Veloso-Pita R; Li J; KuoLee R; Chen W; Vérez-Bencomo V;
    Vaccine; 2012 Nov; 30(50):7332-41. PubMed ID: 22534169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and protective role of an IgA reactive 31-kDa antigen of Vibrio cholerae O139.
    Kumar S; Ray P; Singh H; Ganguly NK
    J Med Microbiol; 2001 Jun; 50(6):489-498. PubMed ID: 11393286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cholera toxin modulates the systemic immune responses against Vibrio cholerae surface antigens after repeated inoculations.
    Fernandez-Miyakawa ME; Brero ML; Mateo NA
    Microbiol Immunol; 2006; 50(8):607-19. PubMed ID: 16924145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experimental studies on cholera immunization. 4. The antibody response to formalinized Vibrio cholerae and purified endotoxin with special reference to protective capacity.
    Svennerholm AM
    Int Arch Allergy Appl Immunol; 1975; 49(4):434-52. PubMed ID: 808500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential immunogenicity of Vibrio cholerae O139 variants expressing different combinations of naturally occurring and atypical forms of the serogroup polysaccharide.
    Attridge SR; Wallerström G; Li BL; Morona R; Holmgren J
    Vaccine; 2009 Feb; 27(7):1055-61. PubMed ID: 19100303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vibrio cholerae O139 conjugate vaccines: synthesis and immunogenicity of V. cholerae O139 capsular polysaccharide conjugates with recombinant diphtheria toxin mutant in mice.
    Kossaczka Z; Shiloach J; Johnson V; Taylor DN; Finkelstein RA; Robbins JB; Szu SC
    Infect Immun; 2000 Sep; 68(9):5037-43. PubMed ID: 10948122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acid-detoxified Inaba lipopolysaccharide (pmLPS) is a superior cholera conjugate vaccine immunogen than hydrazine-detoxified lipopolysaccharide and induces vibriocidal and protective antibodies.
    Grandjean C; Wade TK; Ropartz D; Ernst L; Wade WF
    Pathog Dis; 2013 Mar; 67(2):136-58. PubMed ID: 23620159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides mimicking Vibrio cholerae O139 capsular polysaccharide elicit protective antibody response.
    Falklind-Jerkérus S; Felici F; Cavalieri C; Lo Passo C; Garufi G; Pernice I; Islam MM; Qadri F; Weintraub A
    Microbes Infect; 2005 Dec; 7(15):1453-60. PubMed ID: 16046165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IgM specific to lipopolysaccharide of Vibrio cholerae is a surrogate antibody isotype responsible for serum vibriocidal activity.
    Yang JS; An SJ; Jang MS; Song M; Han SH
    PLoS One; 2019; 14(3):e0213507. PubMed ID: 30845262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Robust gut associated vaccine-specific antibody-secreting cell responses are detected at the mucosal surface of Bangladeshi subjects after immunization with an oral killed bivalent V. cholerae O1/O139 whole cell cholera vaccine: comparison with other mucosal and systemic responses.
    Shamsuzzaman S; Ahmed T; Mannoor K; Begum YA; Bardhan PK; Sack RB; Sack DA; Svennerholm AM; Holmgren J; Qadri F
    Vaccine; 2009 Feb; 27(9):1386-92. PubMed ID: 19146897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunological efficacy of glycoconjugates derived from Vibrio cholerae O1 serotype Ogawa detoxified LPS in mice.
    Paulovičová E; Korcová J; Farkaš P; Bystrický S
    J Med Microbiol; 2010 Dec; 59(Pt 12):1440-1448. PubMed ID: 20724514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological properties of complex conjugates based on Vibrio cholerae O1 Ogawa lipopolysaccharide antigen.
    Paulovicová E; Machová E; Hostacká A; Bystrický S
    Clin Exp Immunol; 2006 Jun; 144(3):521-7. PubMed ID: 16734622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incomplete correlation of serum vibriocidal antibody titer with protection from Vibrio cholerae infection in urban Bangladesh.
    Saha D; LaRocque RC; Khan AI; Harris JB; Begum YA; Akramuzzaman SM; Faruque AS; Ryan ET; Qadri F; Calderwood SB
    J Infect Dis; 2004 Jun; 189(12):2318-22. PubMed ID: 15181581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in capsular content and enhanced bacterial susceptibility to serum killing of Vibrio cholerae O139 associated with the 2002 cholera epidemic in Bangladesh.
    Qadri F; Svennerholm AM; Shamsuzzaman S; Bhuiyan TR; Harris JB; Ghosh AN; Nair GB; Weintraub A; Faruque SM; Ryan ET; Sack DA; Calderwood SB
    Infect Immun; 2005 Oct; 73(10):6577-83. PubMed ID: 16177333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and evaluation of a O139 Vibrio cholerae vaccine candidate based on a hemA gene mutation.
    Ravichandran M; Ali SA; Rashid NH; Kurunathan S; Yean CY; Ting LC; Bakar AS; Lalitha P; Zainuddin ZF
    Vaccine; 2006 May; 24(18):3750-61. PubMed ID: 16102875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A simple and convenient microtiter plate assay for the detection of bactericidal antibodies to Vibrio cholerae O1 and Vibrio cholerae O139.
    Boutonnier A; Dassy B; Duménil R; Guénolé A; Ratsitorahina M; Migliani R; Fournier JM
    J Microbiol Methods; 2003 Dec; 55(3):745-53. PubMed ID: 14607417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.